How many institutions held FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in Q3 2022?

24 institutional investors reported FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share for Q3 2022. Use the holders table for investor-level position and value details.

Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

Q: What does CUSIP 34962G109 represent in this 13F holders report?

CUSIP 34962G109 is the security identifier for FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 34962G109

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 2,668,691
Total 13F value: $2,852,110
Share change: +327,660
Put/Call ratio: 0%
SEC-reported price per share: $1.07
Number of holders: 24
Value change: +$306,315
Number of buys: 10
Number of sells: 18
Shares outstanding: 20,563,488

Security key

34962G109

Report period

Q3 2022

Institutions

Top holders

FBRX full security history Ownership snapshot Full 13F holder table Forte Biosciences, Inc. SEC filings Forte Biosciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

15/15

Latest evidence

30 Jun 2022

13F Lead comparable stake: 2.2% Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 2.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 2.2%

MORGAN STANLEY 1.6%

RENAISSANCE TECHNOLOGIES LLC 1.1%

BlackRock Finance, Inc. 1%

GEODE CAPITAL MANAGEMENT, LLC 0.91%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	2.2%	$599,000 461,134 shares	—	30 Jun 2022
MORGAN STANLEY	13F Company 13F	1.6%	$438,000 336,667 shares	—	30 Jun 2022
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	1.1%	$282,000 216,700 shares	—	30 Jun 2022
BlackRock Finance, Inc.	13F Company 13F	1%	$278,000 214,043 shares	—	30 Jun 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.91%	$242,000 186,598 shares	—	30 Jun 2022
TWO SIGMA ADVISERS, LP	13F Company 13F	0.84%	$225,000 172,991 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,668,691

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

-3

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %